140 related articles for article (PubMed ID: 28041942)
1. Pleiotrophin as a potential biomarker in breast cancer patients.
Ma J; Kong Y; Nan H; Qu S; Fu X; Jiang L; Wang W; Guo H; Zhao S; He J; Nan K
Clin Chim Acta; 2017 Mar; 466():6-12. PubMed ID: 28041942
[TBL] [Abstract][Full Text] [Related]
2. Pleiotrophin serum level and metastasis occurrence in breast cancer patients.
Ikhlas M; Ferianto D; Syamsu SA; Ganda IJ; Smaradania N; Sampepajung E; Anggita CA; Faruk M
Breast Dis; 2024; 43(1):93-98. PubMed ID: 38701136
[TBL] [Abstract][Full Text] [Related]
3. Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Xu C; Wang Y; Yuan Q; Wang W; Chi C; Zhang Q; Zhang X
J Cell Mol Med; 2019 Mar; 23(3):2077-2082. PubMed ID: 30635982
[TBL] [Abstract][Full Text] [Related]
4. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
6. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
Zhou J; Yang Y; Zhang Y; Liu H; Dou Q
PLoS One; 2018; 13(11):e0207473. PubMed ID: 30427932
[TBL] [Abstract][Full Text] [Related]
8. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
9. Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer.
Kong Y; Bai PS; Nan KJ; Sun H; Chen NZ; Qi XG
Int J Colorectal Dis; 2012 Mar; 27(3):287-98. PubMed ID: 22065111
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
11. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
13. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
14. Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.
Liu S; Shen M; Hsu EC; Zhang CA; Garcia-Marques F; Nolley R; Koul K; Rice MA; Aslan M; Pitteri SJ; Massie C; George A; Brooks JD; Gnanapragasam VJ; Stoyanova T
Br J Cancer; 2021 Mar; 124(5):896-900. PubMed ID: 33288843
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
16. Expression of pleiotrophin in small cell lung cancer.
Wang HQ; Wang J
J Biol Regul Homeost Agents; 2015; 29(1):175-9. PubMed ID: 25864755
[TBL] [Abstract][Full Text] [Related]
17. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
18. Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
Yeh HS; Chen H; Manyak SJ; Swift RA; Campbell RA; Wang C; Li M; Lee HJ; Waterman G; Gordon MS; Ma J; Bonavida B; Berenson JR
Br J Haematol; 2006 Jun; 133(5):526-9. PubMed ID: 16681640
[TBL] [Abstract][Full Text] [Related]
19. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
[TBL] [Abstract][Full Text] [Related]
20. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
